Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF

NCT: NCT03047746 · ACTIVE_NOT_RECRUITING

NCT IDNCT03047746
StatusACTIVE_NOT_RECRUITING
Start Date2017-02-01
Completion2029-05
SponsorChildren's Hospital of Philadelphia (OTHER)
First posted
Last updated

Brief Summary

This is a single arm pilot study using TCR alpha/beta+ T cell-depleted peripheral blood stem cells (PBSC) from closely matched unrelated donors or partially matched/haploidentical related donors for hematopoietic stem cell transplant (HSCT) in patients with acquired and inherited bone marrow failure (BMF) syndromes.

Frequently Asked Questions

What is Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF?

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF is a clinical trial registered under NCT03047746. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03047746?

The current status of NCT03047746 (Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF) is: ACTIVE_NOT_RECRUITING.

When did Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF start?

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF started on 2017-02-01.

Related Devices

K250518SMART M-CELL Bone Marrow Concentration SystemMiracell Co., Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑